Beating the internet fraudsters – what it means for pharma

11 November 2016
alphus-hinds-large

In an expert view piece, Alphus Hinds, manager, cyber risk, security and compliance at Tungsten Network, looks at the challenges the pharmaceutical industry faces from invoice fraud.

November 13 marks the start of International Fraud Awareness Week. Organized by the Association of Certified Fraud Examiners, it aims to educate businesses about the impact of fraud and encourage communities to come together in a global effort to fight it. While the week might have passed you by until now, there has never been a more important time to consider whether your business is fraud-proof.

Increasingly, companies are falling foul to internet fraudsters. Over the last couple of months, the headlines have featured huge corporations such as Apple and Netflix, as they have become the latest cybercrime victims.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical